WallStreetZenWallStreetZen

NASDAQ: GLYC
Glycomimetics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GLYC past revenue growth

How has GLYC's revenue growth performed historically?
Company
-100%
Industry
110.58%
Market
14.02%
GLYC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GLYC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

GLYC earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$38.1M
Current Profit Margin
0%

GLYC Return on Equity

Current Company
-73.7%
Current Industry
15.6%
Current Market
-8.4%
GLYC's Return on Equity (-73.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GLYC announces earnings.

GLYC Return on Assets

Current Company
-64.6%
Current Industry
2.2%
GLYC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GLYC Return on Capital Employed

Current Company
-81.32%
Current Industry
17.7%
GLYC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GLYC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GLYC$0.00-$37.01M-$38.07M-100.00%N/A
INO$854.03k-$158.65M-$164.58M-52.88%N/A
HOWL$25.73M-$34.22M-$37.30M+182.13%N/A
SLDB$0.00-$87.92M-$90.83M-100.00%N/A
ANVS$0.00-$37.09M-$37.09MN/AN/A
View Top Biotech Stocks

Glycomimetics Earnings & Revenue FAQ

What were GLYC's earnings last quarter?

On Invalid Date, Glycomimetics (NASDAQ: GLYC) reported Q3 2023 earnings per share (EPS) of -$0.14, up 12.5% year over year. Total Glycomimetics earnings for the quarter were -$9.20 million. In the same quarter last year, Glycomimetics's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Glycomimetics stock.

What was GLYC's earnings growth in the past year?

As of Q4 2023, Glycomimetics's earnings has grown year over year. Glycomimetics's earnings in the past year totalled -$38.07 million.

What was GLYC's revenue last quarter?

On Invalid Date, Glycomimetics (NASDAQ: GLYC) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Glycomimetics's revenue was $0.00.

What was GLYC's revenue growth in the past year?

As of Q4 2023, Glycomimetics's revenue has grown -100% year over year. This is 210.58 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Glycomimetics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.